CGEN FY 2022 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+25.0% YoY

Gross Profit

$7M87.0% margin

Operating Income

-$35M-471.7% margin

Net Income

-$34M-449.3% margin

EPS (Diluted)

$-0.39

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$94M

Total Liabilities

$16M

Stockholders' Equity

$78M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6M	+25.0%
Gross Profit	$7M	$5M	+22.7%
Operating Income	-$35M	-$35M	-0.9%
Net Income	-$34M	-$34M	+1.5%